Arkema Past Earnings Performance

Past criteria checks 2/6

Arkema has been growing earnings at an average annual rate of 2%, while the Chemicals industry saw earnings growing at 7.9% annually. Revenues have been growing at an average rate of 4.7% per year. Arkema's return on equity is 4.7%, and it has net margins of 3.6%.

Key information

2.0%

Earnings growth rate

2.5%

EPS growth rate

Chemicals Industry Growth10.4%
Revenue growth rate4.7%
Return on equity4.7%
Net Margin3.6%
Next Earnings Update06 Nov 2024

Recent past performance updates

Investors Can Find Comfort In Arkema's (EPA:AKE) Earnings Quality

Aug 08
Investors Can Find Comfort In Arkema's (EPA:AKE) Earnings Quality

Recent updates

Investors Can Find Comfort In Arkema's (EPA:AKE) Earnings Quality

Aug 08
Investors Can Find Comfort In Arkema's (EPA:AKE) Earnings Quality

Results: Arkema S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Aug 05
Results: Arkema S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

We Think Arkema (EPA:AKE) Is Taking Some Risk With Its Debt

Jul 16
We Think Arkema (EPA:AKE) Is Taking Some Risk With Its Debt

Arkema's (EPA:AKE) Shareholders Will Receive A Bigger Dividend Than Last Year

May 13
Arkema's (EPA:AKE) Shareholders Will Receive A Bigger Dividend Than Last Year

Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.50

Apr 25
Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.50

Is Arkema (EPA:AKE) A Risky Investment?

Mar 29
Is Arkema (EPA:AKE) A Risky Investment?

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.50

Mar 08
Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.50

Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 02
Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

Dec 30
Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

An Intrinsic Calculation For Arkema S.A. (EPA:AKE) Suggests It's 37% Undervalued

Dec 15
An Intrinsic Calculation For Arkema S.A. (EPA:AKE) Suggests It's 37% Undervalued

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Nov 29
Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?

Sep 07
Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 44%?

Aug 20
Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 44%?

Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?

Aug 02
Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?

Arkema (EPA:AKE) Takes On Some Risk With Its Use Of Debt

May 28
Arkema (EPA:AKE) Takes On Some Risk With Its Use Of Debt

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.40

May 13
Arkema (EPA:AKE) Is Increasing Its Dividend To €3.40

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 25%?

May 09
Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 25%?

Why Arkema S.A. (EPA:AKE) Could Be Worth Watching

Apr 24
Why Arkema S.A. (EPA:AKE) Could Be Worth Watching

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.40

Apr 05
Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.40

Arkema's (EPA:AKE) Dividend Will Be Increased To €3.40

Feb 26
Arkema's (EPA:AKE) Dividend Will Be Increased To €3.40

Arkema (EPA:AKE) Has A Somewhat Strained Balance Sheet

Feb 14
Arkema (EPA:AKE) Has A Somewhat Strained Balance Sheet

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 31%?

Jan 30
Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 31%?

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Jan 14
Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly

Nov 02
Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly

At €76.10, Is Arkema S.A. (EPA:AKE) Worth Looking At Closely?

Oct 11
At €76.10, Is Arkema S.A. (EPA:AKE) Worth Looking At Closely?

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

Jul 19
Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

What Is Arkema S.A.'s (EPA:AKE) Share Price Doing?

Jul 04
What Is Arkema S.A.'s (EPA:AKE) Share Price Doing?

If You Like EPS Growth Then Check Out Arkema (EPA:AKE) Before It's Too Late

Jun 03
If You Like EPS Growth Then Check Out Arkema (EPA:AKE) Before It's Too Late

Arkema's (EPA:AKE) Upcoming Dividend Will Be Larger Than Last Year's

May 10
Arkema's (EPA:AKE) Upcoming Dividend Will Be Larger Than Last Year's

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Apr 25
Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Is There An Opportunity With Arkema S.A.'s (EPA:AKE) 47% Undervaluation?

Apr 24
Is There An Opportunity With Arkema S.A.'s (EPA:AKE) 47% Undervaluation?

Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.00

Apr 10
Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.00

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Mar 27
Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Feb 27
Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Revenue & Expenses Breakdown

How Arkema makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTPA:AKE Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 249,425342913276
31 Mar 249,331349898274
31 Dec 239,514402892275
30 Sep 239,799388877275
30 Jun 2310,445498882273
31 Mar 2311,187752870274
31 Dec 2211,550949858270
30 Sep 2211,5431,050863264
30 Jun 2210,9691,073836257
31 Mar 2210,1801,498815248
31 Dec 219,5191,293788243
30 Sep 219,0041,212768242
30 Jun 218,5151,057755240
31 Mar 218,022350739238
31 Dec 207,884304755241
30 Sep 207,952312796242
30 Jun 208,259365815246
31 Mar 208,611422828251
31 Dec 198,738491812249
30 Sep 198,892561782245
30 Jun 198,843590766242
31 Mar 198,859633761239
31 Dec 188,816674758237
30 Sep 188,566685749235
30 Jun 188,418653743232
31 Mar 188,346594736234
31 Dec 178,326543738235
30 Sep 178,221492733233
30 Jun 178,040446728231
31 Mar 177,794433722227
31 Dec 167,535394705222
30 Sep 167,443390701220
30 Jun 167,551355701218
31 Mar 167,705341693214
31 Dec 157,683285677209
30 Sep 157,354263616194
30 Jun 156,886226555181
31 Mar 156,300144493168
31 Dec 145,952167442155
30 Sep 145,932161430148
30 Jun 145,949202426145
31 Mar 146,058275424143
31 Dec 136,098168429144

Quality Earnings: AKE has high quality earnings.

Growing Profit Margin: AKE's current net profit margins (3.6%) are lower than last year (4.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AKE's earnings have grown by 2% per year over the past 5 years.

Accelerating Growth: AKE's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: AKE had negative earnings growth (-31.3%) over the past year, making it difficult to compare to the Chemicals industry average (-31.3%).


Return on Equity

High ROE: AKE's Return on Equity (4.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies